Copyright
©The Author(s) 2017.
World J Gastroenterol. Jan 21, 2017; 23(3): 437-446
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.437
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.437
Table 3 Variations of α2-Heremans-schmid glycoprotein (g/L) according to patient’s characteristics
| UC | P | CD | P value | |
| Sex | ||||
| Male | 0.34 ± 0.07 | > 0.05 | 0.30 ± 0.08 | > 0.05 |
| Female | 0.34 ± 0.12 | 0.33 ± 0.07 | ||
| Current smoking | ||||
| Yes | 0.31 ± 0.02 | > 0.05 | 0.30 ± 0.01 | > 0.05 |
| No | 0.32 ± 0.01 | 0.28 ± 0.01 | ||
| Age at onset | ||||
| ≥ 40 | NA | - | 0.29 ± 0.01 | > 0.05 |
| < 40 | NA | 0.32 ± 0.02 |
- Citation: Manolakis AC, Christodoulidis G, Kapsoritakis AN, Georgoulias P, Tiaka EK, Oikonomou K, Valotassiou VJ, Potamianos SP. α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease. World J Gastroenterol 2017; 23(3): 437-446
- URL: https://www.wjgnet.com/1007-9327/full/v23/i3/437.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i3.437